SHANGHAI, March 25, 2024 /PRNewswire/ — Filling a gap in the local HMO market, the recently released illuma HMO Liquid Formula is the first in China to contain two essential HMOs, 2′-Fucosyllactose (2′-FL) and Lacto-N-neotetraose (LNnT). This clinically proven product offers substantial…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.